Skip to main content
. Author manuscript; available in PMC: 2010 Feb 12.
Published in final edited form as: Circ Res. 2009 Apr 2;104(9):1095–1102. doi: 10.1161/CIRCRESAHA.108.192138

Figure 5.

Figure 5

Treatment of HUVECs with CD133+ CCM enhanced network formation (A), gap closure (B), and chemotaxis (C), whereas CD133 CCM was less potent. CD133+ CCM blunted HG-induced apoptosis (D). Data are means±SEM. **P<0.01, ***P<0.005 vs nonconditioned medium (NCCM), $P<0.05 vs CD133 cells, ##P<0.01 vs normal glucose.